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non›inferiority of pristinamycin versus penicillin, the
primary end point relies on the per protocol analysis.13
Full application of the intention to treat analysis will be
possible only once complete outcome data become
available for all randomised patients.17 Most of our
non›assessable patients were excluded from the per
protocol analysis because of adverse events leading to
premature withdrawal, missing data, or use of
prohibited treatment. Intention to treat analysis also
confirmed the non›inferiority of pristinamycin as
inclusion of non›compliers decreased the cure rates to
similar extents in both groups.
Currently, pristinamycin is marketed only in some
European countries. It is commonly used in France to
treat erysipelas18 and superficial pyodermas19 in out›
patients. Our results show that pristinamycin could be
an alternative to intravenous then oral penicillin to treat
erysipelas in adult inpatients. Whether this therapeutic
strategy is valid for outpatients needs to be investigated.
We are grateful to C Jean, Y Boutalbi, and O Lescale
(Laboratoire Aventis) for their help in the data analysis and
preparation of the manuscript and P Joffre›Malamas (Labora›
toire Aventis) for the statistical analysis. See bmj.com for a list of
members of the French Erysipelas Study Group.
Contributors: See bmj.com
Funding: Aventis (Paris, France).
Competing interests: PB, OC, and LV have received fees from
Aventis for helping to design and organise the study and review
difficult cases (steering committee).
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Effect of general hospital management on repeat episodes
of deliberate self poisoning: cohort study
Navneet Kapur, Allan House, Kath Dodgson, Chris May, Francis Creed
Provision of services in the United Kingdom for
patients who deliberately poison themselves is variable,
and many patients leave hospital without adequate
assessments.1 This may reflect the equivocal research
evidence on the effectiveness of interventions.2 In this
cohort study, we aimed to investigate whether aspects
of routine hospital management—such as admission,
psychosocial assessment, and referral for follow
up—had an impact on the repetition of deliberate self
poisoning.
Participants, methods, and results
Over eight weeks, we prospectively identified patients
aged over 16 years who attended six general hospitals
(three teaching; three district) in north west England
for deliberate self poisoning. We examined the notes in
accident and emergency departments for all patients
(regardless of presenting complaint) to ensure that we
did not miss any episodes. We also looked at databases
held in wards and emergency departments and copies
of specialists’ self poisoning assessments, and we retro›
spectively checked the patient administration system in
each hospital. We collected information about patients’
characteristics, clinical details, and the management of
the current episode, including whether the patient had
received a psychosocial assessment (as defined by the
Royal College of Psychiatrists).3 We followed partici›
pants for 12 weeks after their index episode, because
half of those who poison themselves again do so within
What is already known on this topic
The reference treatment for erysipelas is
intravenous penicillin, which requires admission to
hospital
Few studies have evaluated the efficacy of oral
treatment for erysipelas
What this study adds
Oral pristinamycin is at least as effective as
intravenous then oral penicillin to treat erysipelas
in adult inpatients, with the advantage of oral first
line treatment
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this period.4 Follow up data were taken from case notes
and databases by a researcher blind to the patient’s ini›
tial management.
In total, 604 people deliberately poisoned them›
selves during the recruitment period; 88 (15%) of these
poisoned themselves again within 12 weeks. Overall,
24/246 (10%) patients who had received a psychoso›
cial assessment and 64/358 (18%) who had not
received an assessment poisoned themselves again
(table). Patients with certain risk factors for repetition—
such as previous self poisoning, psychiatric history, and
substance dependence—were more likely to receive a
psychosocial assessment. We adjusted for these and
other risk factors for repetition—such as sex, age,
potential lethality of the episode, and self discharge
from hospital—with a binary logistic regression model.5
We included psychosocial assessment in the model to
investigate whether such assessment independently
contributed to risk of repetition. After adjustment,
patients who had not been assessed were still more
likely to poison themselves again (adjusted odds ratio
2.3 (95% confidence interval 1.4 to 3.9), P < 0.005).
Comment
Patients who had received a psychosocial assessment
after deliberately poisoning themselves were half as
likely to poison themselves again as those who did not,
even though the patients who were assessed might be
regarded as being at higher risk. The association held
when we adjusted for risk factors for repetition,
although we did not adjust for all possible confound›
ers. The better outcome in those who were assessed
compared with those who were not assessed may have
reflected the type of aftercare, but this study provides
no evidence that referral to a specialist reduced repeti›
tion. Our results suggest that 12 patients need to
receive a psychosocial assessment to prevent one
patient poisoning himself or herself again. If we
assume that 50% of patients are assessed currently, we
might prevent 7000 repeat episodes of self poisoning
by complying with existing guidelines and ensuring
that all patients are properly assessed.3
Our results should be interpreted cautiously because
they are restricted to one region of the United Kingdom
and include a comparatively short follow up period. The
hospitals were representative of the services generally
available for self poisoning,1 however, and most patients
who poison themselves repeat the act soon after the
index episode.4 We did not identify repeat episodes in
patients who did not present to hospital, and this is a
potential source of bias.
Psychosocial assessments have a number of
elements.5 Further research should identify and refine
the components of psychosocial assessments that
reduce the risk of repetition of self poisoning.
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Risk of repetition of self poisoning in 604 patients presenting to six general hospitals in
north west England
Variable
No of
patients
No (%) who
repeated self
poisoning
Odds ratio
(95% CI) for risk
of repetition
Patients’ characteristics
Female 330 52 (16) 0.8 (0.5 to 1.3)
Previous episode of self poisoning 213 41 (19) 1.7 (1.1 to 2.8)
Dependent on drugs or alcohol 111 13 (12) 0.7 (0.4 to 1.4)
Index episode of high potential lethality 145 18 (12) 0.8 (0.5 to 1.4)
Psychiatric contact at time of index episode 112 19 (17) 1.3 (0.7 to 2.2)
Management of index episode
Self discharged before assessment made 91 13 (14) 1.0 (0.5 to 1.8)
Did not receive psychosocial assessment 358 64 (18) 2.1 (1.2 to 3.3)
Admitted to medical ward 208 30 (14) 1.0 (0.6 to 1.6)
Admitted to psychiatric ward 14 3 (21) 1.6 (0.4 to 6.0)
Offered psychiatric follow up 117 18 (15) 1.1 (0.6 to 2.0)
A busy year of reading for medical students?
A liberal education may be had at a very slight cost of time
and money. Well filled though the day be with appointed tasks,
to make the best possible use of your one or of your ten talents,
rest not satisfied with this professional training, but try to get
the education, if not of a scholar, at least of a gentleman.
Before going to sleep read for half an hour, and in the morning
have a book open on your dressing table. You will be surprised
to find how much can be accomplished in the course of a year.
I have put down a list of ten books which you may make close
friends. There are many others; studied carefully in your
student days these will help in the inner education of which
I speak.
I. Old and New Testament.
II. Shakespeare.
III. Montaigne.
IV. Plutarch’s Lives.
V. Marcus Aurelius.
VI. Epictetus.
VII. Religio Medici.
VIII. Don Quixote.
IX. Emerson
X. Oliver Wendell Holmes—Breakfast›Table Series.
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